Physician profile
Ben Ha
NPI 1043305774
$833.65
in general payments reported to CMS, 2019-2025
11 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.56 · 2021: $51.78 · 2022: $270 · 2023: $141 · 2024: $206 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $170.28 | 2022 | |
| Sumitomo Pharma America, INC. | $165.07 | 2023-2024 | Myfembree |
| Organon LLC | $123.05 | 2022-2024 | |
| Shield Therapeutics INC | $79.86 | 2023-2025 | Accrufer |
| Exeltis, USA INC. | $75.32 | 2023-2024 | Slynd |
| Sage Therapeutics, LLC | $64.67 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $51.78 | 2021 | |
| Boston Scientific Corporation | $28.64 | 2019-2023 | Bodyguardian |
| Supernus Pharmaceuticals, INC. | $26.63 | 2025 | Qelbree |
| Gilead Sciences, INC. | $26.54 | 2025 | |
| Avion Pharmaceuticals | $21.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.